These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29240814)

  • 21. Breath-group intelligibility in dysarthria: characteristics and underlying correlates.
    Yunusova Y; Weismer G; Kent RD; Rusche NM
    J Speech Lang Hear Res; 2005 Dec; 48(6):1294-310. PubMed ID: 16478372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensatory articulatory mechanisms preserve intelligibility in prodromal Parkinson's disease.
    Thies T; Mücke D; Geerts N; Seger A; Fink GR; Barbe MT; Sommerauer M
    Parkinsonism Relat Disord; 2023 Jul; 112():105487. PubMed ID: 37329726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria.
    Hammen VL; Yorkston KM; Minifie FD
    J Speech Hear Res; 1994 Apr; 37(2):244-53. PubMed ID: 8028306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Speaking Rate on Variability of Second Formant Frequency Transitions in Dysarthria.
    van Brenk F; Lowit A; Tjaden K
    Folia Phoniatr Logop; 2024; 76(3):295-308. PubMed ID: 37769645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhythmic performance in hypokinetic dysarthria: Relationship between reading, spontaneous speech and diadochokinetic tasks.
    Lowit A; Marchetti A; Corson S; Kuschmann A
    J Commun Disord; 2018; 72():26-39. PubMed ID: 29471176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybridizing conversational and clear speech to investigate the source of increased intelligibility in speakers with Parkinson's disease.
    Tjaden K; Kain A; Lam J
    J Speech Lang Hear Res; 2014 Aug; 57(4):1191-205. PubMed ID: 24686409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Vowel Articulation Analysis in Connected Speech Among Progressive Neurological Diseases, Dysarthria Types, and Dysarthria Severities.
    Illner V; Tykalova T; Skrabal D; Klempir J; Rusz J
    J Speech Lang Hear Res; 2023 Aug; 66(8):2600-2621. PubMed ID: 37499137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.
    Walsh B; Smith A
    Mov Disord; 2012 Jun; 27(7):843-50. PubMed ID: 22729986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nature of speech disorders in Parkinson disease].
    Pawlukowska W; Honczarenko K; Gołąb-Janowska M
    Neurol Neurochir Pol; 2013; 47(3):263-70. PubMed ID: 23821424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study.
    Moya-Galé G; Walsh SJ; Goudarzi A
    J Med Internet Res; 2022 Oct; 24(10):e40567. PubMed ID: 36264608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's Disease.
    Martel-Sauvageau V; Tjaden K
    J Commun Disord; 2017 Nov; 70():1-11. PubMed ID: 29032347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.